Rockwell Medical Inc reports results for the quarter ended December 31 - Earnings Summary

• Rockwell Medical Inc RMTI.OQ reported a quarterly adjusted loss of 2 cents​​ per share for the quarter ended December 31, higher than the same quarter last year, when the company reported EPS of -5 cents. The mean expectation of two analysts for the quarter was for earnings of 2 cents per share.

• Revenue rose 11.6% to $24.67 million from a year ago; analysts expected $23.65 million.

• Rockwell Medical Inc's reported EPS for the quarter was a loss of 2 cents​.

• The company reported a quarterly loss of $755 thousand.

• Rockwell Medical Inc shares had fallen by 13.7% this quarter.

FORECAST CHANGES

• The mean earnings estimate of analysts was unchanged in the last three months.​

• In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 2 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."

• The average consensus recommendation for the pharmaceuticals peer group is also "buy"

Wall Street's median 12-month price target for Rockwell Medical Inc is $6.50

This summary was machine generated from LSEG data March 20 at 11:01 a.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)